Belmadani A, Tramu G, Betbeder A M, Steyn P S, Creppy E E
Laboratory of Toxicology and Applied Hygiene, University Bordeaux II, France.
Arch Toxicol. 1998 Oct;72(10):656-62. doi: 10.1007/s002040050557.
Ochratoxin A (OTA) a chlorodihydro-isocoumarin linked through an amide bond to phenylalanine, is a mycotoxin found as a contaminant in foodstuffs and shown to be nephrotoxic, teratogenic, immunosuppressive, genotoxic, mutagenic and carcinogenic in rodents. Ochratoxin A is known to induce teratogenic effects in neonates (rats and mice) exposed in utero, characterised by microcephaly and modification of the brain levels of free amino acids. Since OTA has been found to accumulate in the brain according to the duration of exposure to doses in the range of natural contamination of feedstuffs, experiments were designed to determine more precisely the structural target of OTA in the brain. After intracerebral injection, OTA (403 ng/10 microl) was not found in the following parts of the brain: the frontal cortex (FC), striatum (ST), ventral mesencephalon (VM) and the cerebellum (CB) in contrast to the rest of the brain, probably due to the detection limit of 0.1 ng/g of tissue. However lactate dehydrogenase (LDH) was increased in extracellular space in the VM to a greater extent than in the rest of the brain, indicating that this structure could be one of the targets of OTA in the brain. Contents of free amino acids were morever similarly modified in the VM and in the rest of the brain. Male rats were given OTA (289 microg/kg per 24 h) by gastric intubation for 8 days and the main brain structures analysed for OTA content and cytotoxicity. OTA was found in the following structures in decreasing order: rest of the brain (50.3%), cerebellum (34.4%), VM (5.1%), striatum (3.3%) and hippocampus (2.9%) of the total OTA amount found in the brain, which represents 0.022% to 0.028% of the given dose. Interestingly cytotoxicity as measured by lactate dehydrogenase (LDH) release in the extracellular space was much more pronounced in the VM, hippocampus, and striatum than in the cerebellum, whereas no cytotoxicity was observed in the rest of the brain. Similarly deoxyribonuclease (DNase) activity in relation to possible necrotic cells was increased in the VM and cerebellum. Altogether these results designated the ventral mesencephalon, hippocampus, striatum and cerebellum as the main OTA-targets in the brain of adult rats and excluded the rest of the brain.
赭曲霉毒素A(OTA)是一种通过酰胺键与苯丙氨酸相连的氯代二氢异香豆素,是一种在食品中作为污染物被发现的霉菌毒素,在啮齿动物中显示出具有肾毒性、致畸性、免疫抑制性、遗传毒性、致突变性和致癌性。已知赭曲霉毒素A会在子宫内接触该毒素的新生动物(大鼠和小鼠)中诱发致畸效应,其特征为小头畸形以及脑中游离氨基酸水平的改变。由于已发现OTA会根据饲料自然污染剂量范围内的接触时长在脑中蓄积,因此设计了实验以更精确地确定OTA在脑中的结构靶点。脑内注射后,与脑的其他部分相比,在脑的以下部位未检测到OTA(403纳克/10微升):额叶皮质(FC)、纹状体(ST)、腹侧中脑(VM)和小脑(CB),这可能是由于组织检测限为0.1纳克/克。然而,VM细胞外空间中的乳酸脱氢酶(LDH)活性比脑的其他部分升高得更多,表明该结构可能是OTA在脑中的靶点之一。此外,VM和脑的其他部分中游离氨基酸的含量变化相似。对雄性大鼠进行胃插管给予OTA(每24小时289微克/千克),持续8天,然后分析主要脑结构中的OTA含量和细胞毒性。在脑中发现OTA的结构及其含量由高到低依次为:脑的其他部分(50.3%)、小脑(34.4%)、VM(5.1%)、纹状体(3.3%)和海马体(2.9%),占脑中发现的OTA总量的比例,这占给药剂量的0.022%至0.028%。有趣的是,通过细胞外空间中乳酸脱氢酶(LDH)释放测定的细胞毒性在VM、海马体和纹状体中比在小脑中更为明显,而在脑的其他部分未观察到细胞毒性。同样,与可能的坏死细胞相关的脱氧核糖核酸酶(DNase)活性在VM和小脑中有所增加。总之,这些结果表明腹侧中脑、海马体、纹状体和小脑是成年大鼠脑中OTA作用的主要靶点,而脑的其他部分则被排除在外。